Efficacy and safety of avatrombopag in the treatment of thrombocytopenia after umbilical cord blood transplantation
Compared with those in the historical control group, our results indicate that AVA could effectively promote platelet engraftment and recovery after UCBT, especially when used in the early period (≤14 days post-UCBT).
Authors
- Mei‐Juan Tu
- Yongsheng Han
- Aijie Huang (ORCID: https://orcid.org/0000-0001-9689-1335)
- Wen Yao
- Tianzhong Pan (ORCID: https://orcid.org/0000-0001-7534-0112)
- Yue Wu (ORCID: https://orcid.org/0000-0003-3449-1170)
- Xiaoyu Zhu (ORCID: https://orcid.org/0000-0002-1111-9141)
- Guangyu Sun (ORCID: https://orcid.org/0000-0001-9101-0463)
- Yaxin Cheng
- Weiwei Wu (ORCID: https://orcid.org/0000-0003-0756-9331)
- Kaidi Song
- Xiang Wan
- Baolin Tang
Institutions
- University of Science and Technology of China (CN)
- Anhui University (CN)
- Shanxi Medical University (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2024-09-10
- DOI
- https://doi.org/10.1097/cm9.0000000000003216
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- National Natural Science Foundation of China
- Anhui Provincial Department of Education
- Natural Science Foundation of Anhui Province